Historical Valuation
Helmerich and Payne Inc (HP) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.74 is considered Undervalued compared with the five-year average of 16.66. The fair price of Helmerich and Payne Inc (HP) is between 39.91 to 77.04 according to relative valuation methord. Compared to the current price of 30.85 USD , Helmerich and Payne Inc is Undervalued By 22.7%.
Relative Value
Fair Zone
39.91-77.04
Current Price：30.85
22.7%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Helmerich and Payne Inc (HP) has a current Price-to-Book (P/B) ratio of 1.09. Compared to its 3-year average P/B ratio of 1.18 , the current P/B ratio is approximately -7.24% higher. Relative to its 5-year average P/B ratio of 1.24, the current P/B ratio is about -11.78% higher. Helmerich and Payne Inc (HP) has a Forward Free Cash Flow (FCF) yield of approximately 3.96%. Compared to its 3-year average FCF yield of 6.75%, the current FCF yield is approximately -41.44% lower. Relative to its 5-year average FCF yield of 5.09% , the current FCF yield is about -22.26% lower.
P/B
Median3y
1.18
Median5y
1.24
FCF Yield
Median3y
6.75
Median5y
5.09
Competitors Valuation Multiple
AI Analysis for HP
The average P/S ratio for HP competitors is 1.17, providing a benchmark for relative valuation. Helmerich and Payne Inc Corp (HP.N) exhibits a P/S ratio of 0.74, which is -36.42% above the industry average. Given its robust revenue growth of 45.83%, this premium appears sustainable.
Performance Decomposition
AI Analysis for HP
1Y
3Y
5Y
Market capitalization of HP increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of HP in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is HP currently overvalued or undervalued?
Helmerich and Payne Inc (HP) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.74 is considered Undervalued compared with the five-year average of 16.66. The fair price of Helmerich and Payne Inc (HP) is between 39.91 to 77.04 according to relative valuation methord. Compared to the current price of 30.85 USD , Helmerich and Payne Inc is Undervalued By 22.70% .
What is Helmerich and Payne Inc (HP) fair value?
HP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Helmerich and Payne Inc (HP) is between 39.91 to 77.04 according to relative valuation methord.
How does HP's valuation metrics compare to the industry average?
The average P/S ratio for HP's competitors is 1.17, providing a benchmark for relative valuation. Helmerich and Payne Inc Corp (HP) exhibits a P/S ratio of 0.74, which is -36.42% above the industry average. Given its robust revenue growth of 45.83%, this premium appears sustainable.
What is the current P/B ratio for Helmerich and Payne Inc (HP) as of Jan 09 2026?
As of Jan 09 2026, Helmerich and Payne Inc (HP) has a P/B ratio of 1.09. This indicates that the market values HP at 1.09 times its book value.
What is the current FCF Yield for Helmerich and Payne Inc (HP) as of Jan 09 2026?
As of Jan 09 2026, Helmerich and Payne Inc (HP) has a FCF Yield of 3.96%. This means that for every dollar of Helmerich and Payne Inc’s market capitalization, the company generates 3.96 cents in free cash flow.
What is the current Forward P/E ratio for Helmerich and Payne Inc (HP) as of Jan 09 2026?
As of Jan 09 2026, Helmerich and Payne Inc (HP) has a Forward P/E ratio of 66.98. This means the market is willing to pay $66.98 for every dollar of Helmerich and Payne Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Helmerich and Payne Inc (HP) as of Jan 09 2026?
As of Jan 09 2026, Helmerich and Payne Inc (HP) has a Forward P/S ratio of 0.74. This means the market is valuing HP at $0.74 for every dollar of expected revenue over the next 12 months.